AI

Akshay Ingale

Director Director DIN 02913746
DIN 02913746 First appointment Jul 2010 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Akshay Ingale

Data last updated:

Akshay Ingale was a Director at Geneombio Technologies Private Limited (2010–2013) and Director at Unita Bioceuticals Private Limited (from 2011). The companies operate in Healthcare.

DIN 02913746
Primary Designation Director
Industry Healthcare
First Appointment 01 Jul 2010
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jul 20102005₹6.07 Cr (FY 2024)Active
Unita Bioceuticals Private Limited U24295MH2011PTC216061
Director11 Apr 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Unita Bioceuticals Private Limited
Geneombio Technologies Private Limited
Premium access

Shareholding and investment profile for Akshay Ingale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay Ingale

Akshay Ingale was first appointed on 01 Jul 2010 as Director at Geneombio Technologies Private Limited. The most recent appointment on record is 11 Apr 2011 at Unita Bioceuticals Private Limited.

Akshay Ingale held 2 earlier board appointments: Geneombio Technologies Private Limited (Director, 01 Jul 2010 to 04 May 2013); Unita Bioceuticals Private Limited (Director, from 11 Apr 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available